A team of researchers from The University of Texas, Austin, has identified an antibody, 'SC27', that could potentially counteract all known variants of the virus causing COVID-19, as well as…
San Diego: A method for finding high-affinity antibody therapeutics that is based on artificial intelligence (AI) has been created by researchers at the University of California San Diego School of…
A large study has begun to find out whether nirsevimab should be offered to all babies in the UK. Source link
The antibody injection had promised a protection boost to those with conditions such as blood cancer. Source link
By Amy Norton HealthDay ReporterTHURSDAY, Aug. 4, 2022 (HealthDay News) -- Researchers are reporting early but encouraging findings on a potential new way to prevent malaria — an old foe…
June 8, 2022 — Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna…
Henny Braund, chief executive of cancer charity Anthony Nolan, said: "This is positive news for blood cancer patients, who we know are less likely to be protected from Covid-19 vaccines…
Lanson Jones, Houston. Howard Huang, MD, pulmonologist, Houston Methodist Hospital. Amesh Adalja, MD, emerging infectious diseases specialist, Johns Hopkins University Center for Health Security. Terry Scoggin, CEO, Titus Regional…
Sept. 22, 2021 -- At least two states are recommending that doctors prioritize the limited supply of monoclonal antibody treatments for high-risk COVID-19 patients, including unvaccinated people who face severe…
The UK-wide scheme for adults who test positive for coronavirus will launch next week. Source link